Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases

作者: J.A McKay , L.J Murray , S Curran , V.G Ross , C Clark

DOI: 10.1016/S0959-8049(02)00234-4

关键词:

摘要: Overexpression of the epidermal growth factor receptor (EGFR) often correlates with an aggressive tumour phenotype and poor prognosis. To examine relevance EGFR in colorectal cancer, we determined expression protein 249 adenocarcinomas 42 lymph node metastases using immunohistochemistry. Moreover, investigated a (CA)(n) dinucleotide repeat polymorphism gene subset 114 tumours. High levels were observed 123/249 (49.4%) samples. carcinomas correlated differentiation grade (P=0.014). However, there no associations Dukes' stage, site, patient age or gender. did not influence survival this cancer cohort (P>or=0.05). Expression was identical paired tumours metastases, only 17/42 (40.5%) samples showing equivalent (P>0.05). The distribution alleles associated These results indicate that while overexpression is common event carcinogenesis, it does

参考文章(26)
Leah N. Klapper, Mark H. Kirschbaum, Michael Seta, Yosef Yarden, Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors Advances in Cancer Research. ,vol. 77, pp. 25- 79 ,(1999) , 10.1016/S0065-230X(08)60784-8
Tetsuya Mitsudomi, Masahiro Tateishi, Teruyoshi Ishida, Keizo Sugimachi, Satoshi Kaneko, Immunohistochemical Evidence of Autocrine Growth Factors in Adenocarcinoma of the Human Lung Cancer Research. ,vol. 50, pp. 7077- 7080 ,(1990) , 10.11501/3078977
Joseph F. Loane, Stephanie Curran, Joy J. Douglas, Howard L. McLeod, Graeme I. Murray, Val G. Ross, Fareeda Y. Ahmed, Judith A. McKay, Expression of Cell Cycle Control Proteins in Primary Colorectal Tumors Does Not Always Predict Expression in Lymph Node Metastases Clinical Cancer Research. ,vol. 6, pp. 1113- 1118 ,(2000)
Horst Buerger, Frank Gebhardt, Hartmut Schmidt, Burkhard Brandt, Werner Boecker, Kirsten Hutmacher, Alf Beckmann, Ralph Lelle, Ronald Simon, Length and Loss of Heterozygosity of an Intron 1 Polymorphic Sequence of egfr Is Related to Cytogenetic Alterations and Epithelial Growth Factor Receptor Expression Cancer Research. ,vol. 60, pp. 854- 857 ,(2000)
Hideko Yamauchi, Vered Stearns, Daniel F. Hayes, When Is a Tumor Marker Ready for Prime Time? A Case Study of c-erbB-2 as a Predictive Factor in Breast Cancer Journal of Clinical Oncology. ,vol. 19, pp. 2334- 2356 ,(2001) , 10.1200/JCO.2001.19.8.2334
H.L. McLeod, J.A. McKay, E.S.R. Collie-Duguid, J. Cassidy, Therapeutic opportunities from tumour biology in metastatic colon cancer. European Journal of Cancer. ,vol. 36, pp. 1706- 1712 ,(2000) , 10.1016/S0959-8049(00)00150-7
S Nicholson, J Richard, C Sainsbury, P Halcrow, P Kelly, B Angus, C Wright, J Henry, JR Farndon, AL Harris, Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup. British Journal of Cancer. ,vol. 63, pp. 146- 150 ,(1991) , 10.1038/BJC.1991.30
Judith A. McKay, Joy J. Douglas, Val G. Ross, Stephanie Curran, Graeme I. Murray, Jim Cassidy, , Cyclin D1 protein expression and gene polymorphism in colorectal cancer International Journal of Cancer. ,vol. 88, pp. 77- 81 ,(2000) , 10.1002/1097-0215(20001001)88:1<77::AID-IJC12>3.0.CO;2-O
Esther Zwick, Peter O. Hackel, Norbert Prenzel, Axel Ullrich, The EGF receptor as central transducer of heterologous signalling systems Trends in Pharmacological Sciences. ,vol. 20, pp. 408- 412 ,(1999) , 10.1016/S0165-6147(99)01373-5